7P41
Crystal Structure of human mARC1 A165T Variant
Summary for 7P41
Entry DOI | 10.2210/pdb7p41/pdb |
Related | 6FW2 |
Descriptor | Mitochondrial amidoxime-reducing component 1,Endolysin,Mitochondrial amidoxime-reducing component 1, oxidanyl(oxidanylidene)molybdenum, PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER, ... (6 entities in total) |
Functional Keywords | molybdenum cofactor, molybdenum enzyme, molybdopterin, pyranopterin, marc, metal binding protein |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 1 |
Total formula weight | 51388.16 |
Authors | Struwe, M.A.,Scheidig, A.J. (deposition date: 2021-07-09, release date: 2021-08-18, Last modification date: 2024-01-31) |
Primary citation | Struwe, M.A.,Clement, B.,Scheidig, A. Letter to the editor: The clinically relevant MTARC1 p.Ala165Thr variant impacts neither the fold nor active site architecture of the human mARC1 protein. Hepatol Commun, 6:3277-3278, 2022 Cited by PubMed: 35560545DOI: 10.1002/hep4.1984 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.6 Å) |
Structure validation
Download full validation report